Literature DB >> 15289761

Mechanism of cerebral edema in children with diabetic ketoacidosis.

Nicole S Glaser1, Sandra L Wootton-Gorges, James P Marcin, Michael H Buonocore, Joseph Dicarlo, E Kirk Neely, Patrick Barnes, Jenny Bottomly, Nathan Kuppermann.   

Abstract

OBJECTIVES: Cerebral edema during diabetic ketoacidosis (DKA) has been attributed to osmotic cellular swelling during treatment. We evaluated cerebral water distribution and cerebral perfusion during DKA treatment in children. STUDY
DESIGN: We imaged 14 children during DKA treatment and after recovery, using both diffusion and perfusion weighted magnetic resonance imaging (MRI). We assessed the apparent diffusion coefficients (ADCs) and measures reflecting cerebral perfusion.
RESULTS: The ADC was significantly elevated during DKA treatment (indicating increased water diffusion) in all regions except the occipital gray matter. Mean reductions in the ADC from initial to postrecovery MRI were: basal ganglia 4.7 +/- 2.5 x 10(-5) mm(2)/s (P=.002), thalamus 3.7 +/- 2.8 x 10(-5) mm(2)/s, (P=.002), periaqueductal gray matter 4.3 +/- 5.1 x 10(-5) mm(2)/s (P=.03), and frontal white matter 2.0 +/- 3.1 x 10(-5) mm(2)/s (P=.03). In contrast, the ADC in the occipital gray matter increased significantly from the initial to postrecovery MRI (mean increase 3.9 +/- 3.9 x 10(-5) mm(2)/s, P=.004). Perfusion MRI during DKA treatment revealed significantly shorter mean transit times (MTTs) and higher peak tracer concentrations, possibly indicating increased cerebral blood flow (CBF).
CONCLUSIONS: Elevated ADC values during DKA treatment suggests a vasogenic process as the predominant mechanism of edema formation rather than osmotic cellular swelling.

Entities:  

Mesh:

Year:  2004        PMID: 15289761     DOI: 10.1016/j.jpeds.2004.03.045

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  45 in total

1.  Change in mean transit time, apparent diffusion coefficient, and cerebral blood volume during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Ken I Marro; Todd L Richards; Joan S Roberts; Parichat Curry; Catherine Pihoker; Heidi Bradford; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

2.  Cognitive dysfunction associated with diabetic ketoacidosis in rats.

Authors:  Nicole Glaser; Steve Anderson; Wesley Leong; Daniel Tancredi; Martha O'Donnell
Journal:  Neurosci Lett       Date:  2012-01-14       Impact factor: 3.046

Review 3.  Hyperglycemic comas in children: new insights into pathophysiology and management.

Authors:  Arlan L Rosenbloom
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

4.  Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Manuel F Casanova; Cornelia D Cudrici; Ekaterina Zakranskaia; Roopa Venugopalan; Sukriti Nag; Michael J Oglesbee; Horea Rus
Journal:  Exp Mol Pathol       Date:  2007-01-30       Impact factor: 3.362

5.  Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children.

Authors:  Nicole S Glaser; Daniel J Tancredi; James P Marcin; Ryan Caltagirone; Yvonne Lee; Christopher Murphy; Nathan Kuppermann
Journal:  J Pediatr       Date:  2013-07-18       Impact factor: 4.406

6.  Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.

Authors:  Nicole S Glaser; Simona Ghetti; T Charles Casper; J Michael Dean; Nathan Kuppermann
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

7.  Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Todd L Richards; Joan S Roberts; Harvey Chiu; Catherine Pihoker; Heidi Bradford; Kristina Deeter; Ken I Marro; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2010-05       Impact factor: 3.624

8.  Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.

Authors:  Predrag Serbedzija; James E Madl; Douglas N Ishii
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

9.  Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide.

Authors:  Nicole Glaser; Natalie Yuen; Steven E Anderson; Daniel J Tancredi; Martha E O'Donnell
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

Review 10.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.